OptumRx Can't Get Motley Rice Disqualified From Opioid MDL

By Mike Curley · March 19, 2024, 2:05 PM EDT

An Ohio federal judge has denied a bid by pharmacy benefit manager OptumRx to disqualify Motley Rice LLC from representing plaintiffs in the national opioid litigation, saying the company hasn't shown...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Recent Articles By Mike

May 16, 2024
NY High Court Blocks Doctor's Hospital Shooting Injury Suit
May 09, 2024
Doc Can't Escape Second Prednisone Overprescribing Suit
April 29, 2024
High Court To Decide Jurisdiction In Dog Food Label Suit
April 26, 2024
Doctor Keeps Trial Win In Death Suit Over Patient's Blood Clot
April 25, 2024
Philips Gets $506M Economic Loss Deal OK'd In CPAP MDL
April 23, 2024
Expert Doc's License Probation Upends $6.5M Med Mal Verdict
April 17, 2024
Compass Group Gets New Damages Trial In $8M Death Suit
April 12, 2024
Asbury Park Escapes Pot Co.'s Zoning Board Conspiracy Suit
April 11, 2024
Pa. Docs Must Face Patient's Post-Op Blood Clot Death Suit
April 04, 2024
NYC Sues 11 Vape Shops Over Sales Of Flavored E-Cigarettes